Keyphrases
3-group
25%
Biochemical Failure
25%
Cancer Center
25%
Cause-specific Survival
25%
Clinical High Risk
50%
CyberKnife
75%
Failure-free
25%
High-risk Population
25%
Image-guided
100%
Intermediate Risk
25%
Intermediate-risk Group
25%
Localized Prostate Cancer
100%
Low Risk
25%
Low-risk Group
25%
Progression-free Survival
25%
Prostate Carcinoma
25%
Rectal Toxicity
25%
Stereotactic Body Radiation Therapy
100%
Survival Rate
25%
Treatment Modalities
25%
Treatment Toxicity
25%
Urinary Toxicity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
33%
Biochemical Recurrence
33%
Cause Specific Survival
33%
Malignant Neoplasm
33%
Progression Free Survival
33%
Prostate Cancer
100%
Retrospective Study
33%
Survival Rate
66%